Sangamo Therapeutics Announces Participation at Upcoming Investor Conferences

Published

BRISBANE, Calif.--(BUSINESS WIRE)-- Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that members of the management team will present at the following investor and industry conferences in October:

Cell & Gene Meeting on the Mesa 2019 Corporate presentation Wednesday, Oct 2nd at 3:15 p.m. Pacific Time Location: Carlsbad, CA

Panel: What does the future hold for gene editing? Friday, Oct 4th at 9:45 a.m. Pacific Time Location: Carlsbad, CA

Cantor Global Healthcare Conference 2019 Friday, Oct 4th at 11:15 a.m. Eastern Time Location: New York, NY

Chardan 3rd Annual Genetic Medicines Conference Monday, Oct 7th at 8:30 a.m. Eastern Time Location: New York, NY

Jefferies Gene Therapy/Editing Summit Tuesday, Oct 8th at 11:15 a.m. Eastern Time Location: New York, NY

Presentations will be webcast live and may be accessed via a link on the Sangamo Therapeutics website in the Investors and Media section under Events and Presentations. The presentations will also be available on the Sangamo website after the event.

About Sangamo Therapeutics

Sangamo Therapeutics is committed to translating ground-breaking science into genomic medicines with the potential to transform patients’ lives using gene therapy, ex vivo gene-edited cell therapy, and in vivo genome editing and gene regulation. For more information about Sangamo, visit www.sangamo.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20190930005267/en/

Investor Relations – Global McDavid Stilwell 510-970-6000, x219 mstilwell@sangamo.com

Media Inquiries – Global Aron Feingold 510-970-6000, x421 afeingold@sangamo.com

Source: Sangamo Therapeutics, Inc.

In This Story

SGMO